An audit of growth hormone replacement for GH-deficient adults in Scotland

Sam Philip; Isobel Howat; Maggie Carson; Anne Booth; Karen Campbell; Donna Grant; Catherine Patterson; Christopher Schofield; John Bevan; Alan Patrick; Graham Leese; John Connell

doi:10.1111/cen.12017

An audit of growth hormone replacement for GH-deficient adults in Scotland

Sam Philip, Isobel Howat, Maggie Carson, Anne Booth, Karen Campbell, Donna Grant, Catherine Patterson, Christopher Schofield, John Bevan, Alan Patrick, Graham Leese, John Connell

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Guidelines on the clinical use of growth hormone therapy in adults were issued by the UK National Institute for Clinical Excellence (NICE) in August 2003. We conducted a retrospective clinical audit on the use of growth hormone (GH) in Scotland to evaluate the use of these guidelines and their impact on clinical practice. The audit had two phases. In phase I, the impact of NICE criteria on specialist endocrine practice in starting and continuing GH replacement was assessed. In phase II, the reasons why some adults in Scotland with growth hormone deficiency were not on replacement therapy were evaluated.

Original language	English
Pages (from-to)	571-576
Number of pages	6
Journal	Clinical Endocrinology
Volume	78
Issue number	4
DOIs	https://doi.org/10.1111/cen.12017
Publication status	Published - Apr 2013

Access to Document

10.1111/cen.12017

Cite this

@article{a946e1ef59ac4f0eb4d72c1c8b32fdfe,

title = "An audit of growth hormone replacement for GH-deficient adults in Scotland",

abstract = "Guidelines on the clinical use of growth hormone therapy in adults were issued by the UK National Institute for Clinical Excellence (NICE) in August 2003. We conducted a retrospective clinical audit on the use of growth hormone (GH) in Scotland to evaluate the use of these guidelines and their impact on clinical practice. The audit had two phases. In phase I, the impact of NICE criteria on specialist endocrine practice in starting and continuing GH replacement was assessed. In phase II, the reasons why some adults in Scotland with growth hormone deficiency were not on replacement therapy were evaluated.",

author = "Sam Philip and Isobel Howat and Maggie Carson and Anne Booth and Karen Campbell and Donna Grant and Catherine Patterson and Christopher Schofield and John Bevan and Alan Patrick and Graham Leese and John Connell",

year = "2013",

month = apr,

doi = "10.1111/cen.12017",

language = "English",

volume = "78",

pages = "571--576",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - An audit of growth hormone replacement for GH-deficient adults in Scotland

AU - Philip, Sam

AU - Howat, Isobel

AU - Carson, Maggie

AU - Booth, Anne

AU - Campbell, Karen

AU - Grant, Donna

AU - Patterson, Catherine

AU - Schofield, Christopher

AU - Bevan, John

AU - Patrick, Alan

AU - Leese, Graham

AU - Connell, John

PY - 2013/4

Y1 - 2013/4

N2 - Guidelines on the clinical use of growth hormone therapy in adults were issued by the UK National Institute for Clinical Excellence (NICE) in August 2003. We conducted a retrospective clinical audit on the use of growth hormone (GH) in Scotland to evaluate the use of these guidelines and their impact on clinical practice. The audit had two phases. In phase I, the impact of NICE criteria on specialist endocrine practice in starting and continuing GH replacement was assessed. In phase II, the reasons why some adults in Scotland with growth hormone deficiency were not on replacement therapy were evaluated.

AB - Guidelines on the clinical use of growth hormone therapy in adults were issued by the UK National Institute for Clinical Excellence (NICE) in August 2003. We conducted a retrospective clinical audit on the use of growth hormone (GH) in Scotland to evaluate the use of these guidelines and their impact on clinical practice. The audit had two phases. In phase I, the impact of NICE criteria on specialist endocrine practice in starting and continuing GH replacement was assessed. In phase II, the reasons why some adults in Scotland with growth hormone deficiency were not on replacement therapy were evaluated.

U2 - 10.1111/cen.12017

DO - 10.1111/cen.12017

M3 - Article

C2 - 22901318

SN - 0300-0664

VL - 78

SP - 571

EP - 576

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 4

ER -

An audit of growth hormone replacement for GH-deficient adults in Scotland

Abstract

Access to Document

Fingerprint

Cite this